We are the movement to beat rare cancers

Since 2007, we’ve raised more than $377 million for rare cancer research at MSK. Thank you for riding, donating, and supporting our mission to help us reach this extraordinary milestone.

Join us in 2025! Fill out our interest form to be the first to know when registration opens.

Sign up

[[ label ]]

[[ formatted_raised ]]   raised

Search for a Participant

Search for a Team



Bailey's Warriors

$ 1,139,886


Team Blackstone 2024

$ 928,037


Team JPMorgan Chase

$ 500,000


Bike with Mike

$ 432,115


Good AS Gold

$ 355,834


Hazel Strong

$ 354,993


Team Ladyhawk

$ 314,577


Georgetown Field Hockey

$ 270,874


Team Perry

$ 264,968


Team Y&B

$ 244,457

Top National Teams

Where impact meets inspiration

Where impact meets inspiration

Thank you to everyone who took part in our 2024 season! From the riders who showed up at events across the country to the donors who supported them, we want to extend our heartfelt gratitude to this extraordinary community. Watch as we revisit some of our favorite memories from this season and see why together, we are the movement to beat rare cancers.

Watch the Video

Official Performance Apparel Sponsor

Official Performance Apparel Sponsor

We are so grateful to partner with Vuori, the Official Performance Apparel Sponsor of Cycle for Survival. Follow your team on the leaderboard and check out your per bike average (PBA). When you reach PBA milestones, you’ll earn exclusive Cycle for Survival gear from Vuori!


Equinox is the founding partner of Cycle for Survival. Equinox’s unwavering support has helped the events grow exponentially, from one cycling studio in New York City to large events across the country. Its world-renowned cycling instructors lead each ride, and Equinox’s leadership and staff dedicate significant time and resources to raise awareness and funds.


The movement to beat rare cancers



of every dollar

funds research and clinical trials at MSK. Your support builds a better future for every person facing a rare cancer.



has been raised by riders and donors since 2007, funding new FDA-approved drugs, countless lifesaving advances, and the innovative technology that makes it all possible.


MSK’s world-leading expertise

means that discoveries made here benefit people globally. MSK physicians care for people with more than 400 types of cancer each year, including some of the rarest forms.